Drug Type Small molecule drug |
Synonyms- |
Action inhibitors |
Mechanism TNF inhibitors(Tumor necrosis factor inhibitors), TNF-α inhibitors(Tumor necrosis factor α inhibitors), TNFR inhibitors(Tumor necrosis factor receptor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Atherosclerosis | Discovery | - | 02 Apr 2024 | |
Endocrinology and Metabolic Disease | Discovery | - | 02 Apr 2024 | |
Glomerulonephritis | Discovery | - | 02 Apr 2024 | |
Hemic and Lymphatic Diseases | Discovery | - | 02 Apr 2024 | |
Hepatitis C | Discovery | - | 02 Apr 2024 | |
Immune System Diseases | Discovery | - | 02 Apr 2024 | |
Neoplasms | Discovery | - | 02 Apr 2024 | |
Other Diseases | Discovery | - | 02 Apr 2024 | |
Respiratory Diseases | Discovery | - | 02 Apr 2024 | |
Skin and Musculoskeletal Diseases | Discovery | - | 02 Apr 2024 |